tirzepatide is a glp 1 Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology GLP-1/GIP Tirzepatide

GHK-Cu Versus the Proven Standards of Care The fairest way to calibrate GHK-Cus evidence is to set it beside the two agents that actually cleared the regulatory bar for androgenetic alopecia

Plaintiffs allege that GLP-1 medications such as Ozempic, Wegovy, and Mounjaro caused severe gastrointestinal complications, including gastroparesis and intestinal blockages

Non-selective NSAIDs (aspirin, naproxen [e.g., Aleve], ibuprofen [e.g., Advil], diclofenac [e.g., Cambia], and indomethacin [Indocin]) inhibit the activity of both COX enzymes (Conaghan 2012)

While 7.5 mg is a mid-range dose for Tirzepatide, it would be an extremely high, unsafe dose for Semaglutide

Key limitations: State boards scrutinize scope: Prescribing solely for obesity (a metabolic condition) may be viewed as outside a psychiatric NPs training